Janus Henderson Group
GBT

Janus Henderson Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Janus Henderson Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,190,686
Closed -$149M – 2656
2022
Q3 		$149M Sell
2,190,686
-2,287,562
-51% -$126M 0.06% 283
2022
Q2 		$143M Sell
4,478,248
-1,125,007
-20% -$32.9M 0.1% 206
2022
Q1 		$194M Buy
5,603,255
+120,091
+2% +$3.59M 0.09% 209
2021
Q4 		$160M Sell
5,483,164
-789,518
-13% -$24.5M 0.07% 269
2021
Q3 		$160M Buy
6,272,682
+104,532
+2% +$3.07M 0.07% 271
2021
Q2 		$216M Buy
6,168,150
+285,575
+5% +$11.1M 0.09% 226
2021
Q1 		$240M Sell
5,882,575
-84,287
-1% -$3.87M 0.11% 200
2020
Q4 		$258M Buy
5,966,862
+540,580
+10% +$26.7M 0.12% 183
2020
Q3 		$299M Buy
5,426,282
+891,029
+20% +$56.6M 0.16% 149
2020
Q2 		$286M Sell
4,535,253
-18,728
-0.4% -$1.28M 0.16% 146
2020
Q1 		$233M Buy
4,553,981
+1,555,086
+52% +$104M 0.16% 145
2019
Q4 		$238M Buy
2,998,895
+549,524
+22% +$32.6M 0.12% 191
2019
Q3 		$119M Buy
2,449,371
+16,766
+0.7% +$874K 0.06% 318
2019
Q2 		$128M Sell
2,432,605
-83,760
-3% -$4.81M 0.07% 313
2019
Q1 		$133M Sell
2,516,365
-6,903
-0.3% -$339K 0.07% 309
2018
Q4 		$104M Sell
2,523,268
-744,770
-23% -$27.9M 0.07% 335
2018
Q3 		$124M Sell
3,268,038
-886,347
-21% -$39.3M 0.07% 338
2018
Q2 		$188M Buy
4,154,385
+452,843
+12% +$20.6M 0.11% 242
2018
Q1 		$179M Buy
3,701,542
+672,760
+22% +$37.5M 0.11% 237
2017
Q4 		$119M Buy
3,028,782
+1,613,224
+114% +$60.3M 0.07% 330
2017
Q3 		$44M Buy
1,415,558
+431,325
+44% +$12.1M 0.03% 552
2017
Q2 		$26.9M Buy
+984,233
New +$29.3M 0.02% 668

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Janus Henderson Group's GBT Position: Q4 2022 in Review

Janus Henderson Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 2,190,686 shares — an estimated $149M sold.

Janus Henderson Group first reported a position in GBT in Q2 2017 and held it in 22 quarters. The position peaked at $299M in Q3 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Janus Henderson Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Janus Henderson Group sold 2,190,686 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $149M.
  • Janus Henderson Group first reported a position in Global Blood Therapeutics, Inc. in Q2 2017 and held it in 22 quarters.
  • Janus Henderson Group's Global Blood Therapeutics, Inc. position peaked at $299M in Q3 2020.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.